# FDA Inspection 1100903 - Atomvie Global Radiopharma Inc. - July 19, 2019

Source: https://www.keypedia.com/records/fda_inspections/atomvie-global-radiopharma-inc/bfbb1fc2-a85a-429e-9a03-831ab4e0d36d
Source feed: FDA_Inspections

> FDA Inspection 1100903 for Atomvie Global Radiopharma Inc. on July 19, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1100903
- Company Name: Atomvie Global Radiopharma Inc.
- Inspection Date: 2019-07-19
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1045820 - 2018-03-27](https://www.keypedia.com/records/fda_inspections/atomvie-global-radiopharma-inc/bb801417-85ba-418e-b4b6-b91100b52797)
- [FDA Inspection 843934 - 2013-07-26](https://www.keypedia.com/records/fda_inspections/atomvie-global-radiopharma-inc/d55a6a9e-0bb7-4611-9746-85fac64c0c7e)

Company: https://www.keypedia.com/companies/atomvie-global-radiopharma-inc/fcd577a4-28d4-4a50-93dd-a5d7a1d6261a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c